Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

Next Previous
Trial Profile

Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Epacadostat (Primary) ; Capecitabine; Oxaliplatin
  • Indications Rectal cancer
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 02 Jun 2023 Phase of the trial changed from phase 1 to phase 1/2. Number of treatment arms increased from 2 to 3 by the addition of Active Comparator: Phase II Biomarker Cohort: SCRT + Chemotherapy + Surgery arm. Phase 2 primary efficacy end-point is added, thus making "TU" also a trial focus.
    • 02 Jun 2023 Planned End Date changed from 30 Jun 2027 to 12 Aug 2030.
    • 02 Jun 2023 Planned primary completion date changed from 31 Dec 2026 to 15 Jul 2027.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top